These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9212805)

  • 1. [Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
    Morishima Y; Tashiro T; Yamamori H; Takagi K; Ohtsubo Y; Sugiura T; Hayashi N; Furukawa K; Itabashi T; Sano W; Toyoda Y; Nitta H; Nakajima N
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):965-9. PubMed ID: 9212805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
    Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidisciplinary treatment of cancer of the esophagus].
    Hoshino A; Nishihira T; Hirayama K; Shineha R; Mori S
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1141-6. PubMed ID: 8333741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
    J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
    Kakegawa T; Yamana H; Fujita H; Shinozaki K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1173-8. PubMed ID: 8333745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, vindesine, pepleomycin and combined radiation therapy for inoperable esophageal carcinoma.
    Saito T; Kinoshita T; Shigemitsu Y; Shimoda K; Katsuta T; Miyahara M; Kobayashi M; Ashizawa A
    Jpn J Clin Oncol; 1993 Apr; 23(2):123-9. PubMed ID: 7685835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
    Bedenne L; Michel P; Bouché O; Milan C; Mariette C; Conroy T; Pezet D; Roullet B; Seitz JF; Herr JP; Paillot B; Arveux P; Bonnetain F; Binquet C
    J Clin Oncol; 2007 Apr; 25(10):1160-8. PubMed ID: 17401004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
    Kaneko K; Ito H; Ito T; Konishi K; Kurahashi T; Yamamoto T; Eguchi J; Kitahara T; Mitamura K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):831-4. PubMed ID: 11432353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
    Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of stage IV esophageal cancer successfully treated by chemoradiation].
    Kobayashi T; Yoshida M; Kawabe A; Isogaki J; Wada H; Kazui T; Nozue M; Nishimura T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2233-6. PubMed ID: 10635310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
    Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
    J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced esophageal carcinoma successfully treated with chemoradiation therapy with low-dose cisplatin and 5-fluorouracil].
    Oyama K; Hirosawa H; Ito H; Fukushima W; Masutani H; Kadoya N; Izumi R; Hirono T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):899-903. PubMed ID: 10897218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete remission of esophageal undifferentiated carcinoma with nedaplatin and 5-FU chemotherapy and endoesophageal brachytherapy].
    Nemoto H; Takeuchi S; Nagasaki H; Yoshizawa Y; Kikuchi H; Yagi H; Midorikawa T; Sanada Y; Kumada K; Iwashige M; Takizawa K; Tate G
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):263-7. PubMed ID: 12610877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoradiation therapy for advanced esophageal cancers--report of 3 cases].
    Yoshida S; Todoroki T; Koike N; Maruyama T; Kawamoto T; Fukao K; Shimizu W; Ohara K; Monoi H; Yamamoto Y; Kawai Y
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1343-7. PubMed ID: 10478190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.